Michael D Ries Selected Research

ultra-high molecular weight polyethylene (UHMWPE)

1/2016	Effect of processing, sterilization and crosslinking on UHMWPE fatigue fracture and fatigue wear mechanisms in joint arthroplasty.
4/2013	Clinical trade-offs in cross-linked ultrahigh-molecular-weight polyethylene used in total joint arthroplasty.
1/2013	Monitoring and risk of progression of osteolysis after total hip arthroplasty.
10/2011	Tradeoffs amongst fatigue, wear, and oxidation resistance of cross-linked ultra-high molecular weight polyethylene.
1/2008	How prevalent are implant wear and osteolysis, and how has the scope of osteolysis changed since 2000?
6/2005	Highly cross-linked polyethylene: the debate is over--in opposition.
12/2004	Fatigue crack propagation resistance of highly crosslinked polyethylene.
5/2004	Early failure due to osteolysis associated with contemporary highly cross-linked ultra-high molecular weight polyethylene. A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Ries Research Topics

Disease

11	Osteolysis 01/2014 - 01/2003
10	Infections 01/2021 - 07/2002
4	Osteoarthritis 01/2018 - 10/2008
4	Fatigue 01/2016 - 12/2004
3	Pain (Aches) 01/2020 - 08/2007
2	Stress Fractures (Stress Fracture) 01/2016 - 04/2013
2	Periprosthetic Fractures 01/2014 - 12/2012
2	Necrosis 05/2006 - 06/2002
2	Wounds and Injuries (Trauma) 11/2004 - 06/2002
2	Hemophilia A (Haemophilia) 11/2004 - 07/2002
2	Joint Diseases (Joint Disease) 10/2004 - 07/2002
1	Clostridium Infections 12/2021
1	Hip Dislocation 01/2021
1	Contracture 12/2019
1	Postoperative Pain 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2014
1	Arthritis (Polyarthritis) 12/2013
1	Congenital Abnormalities (Deformity) 12/2013
1	Osteoporotic Fractures 12/2012
1	Osteoporosis 12/2011
1	Reinfection 09/2010
1	Edema (Dropsy) 10/2008
1	Obesity 12/2006
1	Hip Fractures (Intertrochanteric Fractures) 04/2005
1	Diabetes Mellitus 11/2004
1	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 11/2004
1	Persistent Infection 11/2004
1	Infectious Arthritis (Septic Arthritis) 04/2004
1	Abscess 04/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2003
1	HIV Infections (HIV Infection) 07/2002

Drug/Important Bio-Agent (IBA)

8	ultra-high molecular weight polyethylene (UHMWPE)IBA 01/2016 - 05/2004
4	Polyethylene (Polythene)IBA 01/2014 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 10/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2010 - 04/2005
1	3,5-tetrahydroaldosterone sulfate (THAS)IBA 12/2021
1	ZirconiumIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 12/2019
1	PolymersIBA 01/2016
1	Vancomycin FDA LinkGeneric 01/2014
1	Free RadicalsIBA 10/2011
1	hylanIBA 04/2004
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2003
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2002

Therapy/Procedure

16	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2019 - 06/2002
12	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2014 - 01/2003
10	Arthroplasty 01/2021 - 07/2002
3	Aftercare (After-Treatment) 01/2014 - 11/2004
2	Surgical Amputation (Amputations) 01/2014 - 11/2004
2	Osteotomy 04/2005 - 02/2003
1	Replantation 01/2021
1	Denervation 01/2020
1	Tourniquets 01/2019
1	Bone Transplantation (Bone Grafting) 12/2011
1	Replacement Arthroplasty 10/2011
1	Debridement 09/2010
1	Therapeutics 09/2010
1	Contraindications 12/2006
1	Operative Time 08/2005
1	Free Tissue Flaps 11/2004
1	Intra-Articular Injections 04/2004
1	Prostheses and Implants (Prosthesis) 07/2002
1	Skin Transplantation (Skin Grafting) 06/2002